Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vifa2g03111 | ATGAAACCCCTCTACAGCACCAACACTCTCTTACTCCTCCTTGCTCTATTCCTTCTCCACTTAGGACCATCCCACTCTTCAACTTCAGCCTCTCAACTTCTCTACTTCAAACAATCTCTCCCTAACCCATCCCTCCTCCATGACTGGCTCCCTTCCAGAAACCCATGCTCCTTCACTGGCATCACCTGCAACCAAACCACCGTTACTTCCATAGACCTCACCTCCATCCCTCTCAGCACAAATCTCACCGTCGTCGCCACCTACCTTCTCACCCTCGACCACCTCCAAATCCTCACCTTGAAATCCTCCAACATCACTTCCTCTCCCATTTCCCTCTCCCACACCAAGTGCACTTCCTCACTCACCTCCCTAGATCTATCACAAAACACTATCTCCTCCTCTTTCTCCAACTTTTCCTTTCTCTCATCATGCTCCGCTCTTAAATCTCTTAACCTCTCCAACAACCTGCTCGCCTTCGATTCTCCCAAATGGACTCTCCCTTCGTCTCTCCGCTTTCTCGACGTTTCCAACAACAAGATTTCCGGCCCTGGATTCTTCCCTTGGATCCTTAACCATGACTTAGAGTTTTTATCTCTCAGAGGAAACAAAGTCACCGGCGAAACCGACTTCTCCGGTTACAAAACTCTCAAGTATCTAGATATTTCCTCTAATAATTTCACTGTCTCTATACCTTCCTTCGGTGACTGTTCATCTCTCACACACCTCGATATCTCTGCAAATAAATACTTCGGCGACATTACCAGAACTCTCTCCCCTTGCAAAAACCTCCTCCATCTCAACCTCTCCGGCAACCAGTTCACCGGCGCCGTTCCTTCTCTTCCTTCTGGCTCCCTACAGTTCCTCTACCTTGCTGAAAACCACTTCGCCGGAATAATCCCGCCGCGTCTGGCTGACCTCTGCTCAACTCTCATCGAACTCGATCTCTCTTCCAACAACCTCACCGGTCCAGTCCCACGCGAGTTCGGCGCGTGCAGTTTGTTGAAGTCTTTCGACATATCGAGCAACAAGTTCGCCGGTGAACTTCCGATGGAGATTCTAACTGAGATGAGTGGTTTGAAAGAACTGACCGTGTCGTTTAACGAATTTTCTGGTCTACTTCCCGAGTCGCTGTCAAAGTTAACGGGTTTGGAATCGTTAGATCTGAGTTCGAATAACTTCAGCGGAACGATTCCGAGGTGGCTTTGCGGAGAAGAATGGGGGAATAATTTGAAGGGACTTTACCTGCAAAATAACGTGTTCACGGGTTTTATTCCTCCAACGCTGAGTAACTGTTCTAACCTCGTTGCTCTTGATTTCAGTTTCAATTACCTCACGGGAACCATTCCTCCGAGTTTAGGTTCGCTTTCGAAGCTTCGCGACTTAATCATGTGGTTGAATCAGCTTCACGGGGAGATTCCTCAAGAGCTTCGAGATATGGCGAGTCTTGAGAATTTGATTCTTGATTTTAATGAGTTGAGTGGAACCATTCCTTCGGGGCTGGTGAATTGCACTAAGCTGAATTGGATCTCGCTGTCGAATAACAGGCTTACCGGGGAGATTCCTTCGTGGATTGGGAAGCTTTCGAATCTTGCTATATTGAAACTGAGTAATAACTCGTTCTCTGGGAGGATTCCGCCGGAGTTGGGAGATTGCCCTAGCTTGATATGGTTGGATCTGAATACAAATTTTCTTACTGGACCGATACCTCCTGAGTTGGCGAAGCAATCGGGGAAAGTTGTGGTTAATTTCATCAGTGGGAAGACATATGTTTACATTAAGAATGATGGTAGTAAAGAGTGTCATGGAGCTGGGAGCTTGCTGGAATTTGCAGGGATTAATCAGGAACAATTGGGGAGAATTTCAACAAGGAACCCTTGCAATTTCACTAGGGTTTATGGAGGTAAGCTTCAGCCTACGTTTACGCTTAATGGCTCGATGATCTTTTTGGATGTTTCACACAACATGTTGTCTGGTACTATTCCTAAGGAAATTGGTGAAATGGTATTTCTCTATGTTTTGCATTTGAGTCATAATAACCTATCTGGTAGCATTCCTCAAGAGCTTGGTAGGATGAAGAATCTCAATATTCTTGATCTTTCTTACAATAAGTTGCAAGATCAAATTCCACAAACCTTAACAAGGCTTTCATTGCTCACTGAGATTGACTTCTCCAACAATTGTCTCTCTGGAACGATTCCGGAATCTGGTCAATTTGACACGTTTCCGGTTGGTAAGTTCCTGAACAACTCTGGTCTCTGCGGTGTTCCTCTTCCACCGTGTGGGGCGGACTTGGGAGGGGGTGCAGGTTCGCAGCATAAGTCTCATAGGAGACAGGCGTCTCTTGCAGGGAGTGTGGCAATGGGATTGCTTTTCTCTCTTTTCTGTGTTTTCGGTTTGATCATTATTGCTATTGAGACAAGAAAGAGGAGGAAGAAAAAAGAGGCAGCTATTGATGGCTACATTGAAAATTCTCATTCTGGCAATGCCAATAATTCTGGCTGGAAATTGACCAGTGCCCGCGAAGCTCTCAGTATTAACCTCGCAACGTTTGAAAAGCCACTTCGAAAGCTCACTTTCGCAGATCTTCTAGCAGCAACCAATGGCTTTCACAATGACAGTCTCATTGGTTCAGGTGGTTTCGGCGATGTGTATAAAGCTCAGTTGAAAGACGGAAGTGTTGTGGCCATCAAGAAGCTGATACATGTAAGTGGACAAGGGGACAGAGAATTCACAGCTGAAATGGAAACCATTGGGAAAATTAAGCACAGAAACCTTGTTCCTCTTCTGGGATACTGCAAGGTTGGAGAGGAAAGACTGTTGGTTTATGAGTACATGAAATATGGAAGTCTAGAAGATGTCCTGCACGACCCGAAGAAAGCTGGGATCAAGATGAATTGGTCAGTGAGGAGGAAGATTGCAATTGGAGCTGCAAGAGGGTTGGCTTTTCTCCACCATAACTGTATTCCACATATCATTCACAGAGACATGAAATCCAGCAATGTCTTGCTCGATGAAAATTTGGAAGCCAGGGTCTCTGATTTTGGTATGGCTAGGCTTATGAGTGCTATGGACACACATTTGAGTGTAAGCACATTGGCGGGCACGCCGGGTTATGTTCCTCCAGAATACTATCAAAGCTTTAGATGCTCCACTAAAGGCGACGTTTATAGTTATGGTGTAGTTTTGCTGGAGTTGCTGACGGGGAAAAGACCAACCGATTCAGCTGATTTTGGCGATAACAATCTTGTCGGATGGGTTAAACAACATGCCAAACTCAAAATAAGTGATGTCTTTGATAAAGAGCTTATGAAAGAAGACCCCAATTTGGAGATCGAGCTTTTGCAGCATTTAAAGGTAGCTTGTGCTTGTTTGGACGATAGACCTTGGAGGAGACCTACAATGATTCAAGTCATGGCAATGTTCAAGGAAATACAAGCAGGTTCAGGAATGGATTCTCAGTCTACTATAGCCGCTGAAGACGAAGGTTTCAACGCCATCGAAATGGTTGAAATGAGCATAAAAGAAGTCCCTGAATCAAACAAGCATTAA | 3549 | 0.4528 | MKPLYSTNTLLLLLALFLLHLGPSHSSTSASQLLYFKQSLPNPSLLHDWLPSRNPCSFTGITCNQTTVTSIDLTSIPLSTNLTVVATYLLTLDHLQILTLKSSNITSSPISLSHTKCTSSLTSLDLSQNTISSSFSNFSFLSSCSALKSLNLSNNLLAFDSPKWTLPSSLRFLDVSNNKISGPGFFPWILNHDLEFLSLRGNKVTGETDFSGYKTLKYLDISSNNFTVSIPSFGDCSSLTHLDISANKYFGDITRTLSPCKNLLHLNLSGNQFTGAVPSLPSGSLQFLYLAENHFAGIIPPRLADLCSTLIELDLSSNNLTGPVPREFGACSLLKSFDISSNKFAGELPMEILTEMSGLKELTVSFNEFSGLLPESLSKLTGLESLDLSSNNFSGTIPRWLCGEEWGNNLKGLYLQNNVFTGFIPPTLSNCSNLVALDFSFNYLTGTIPPSLGSLSKLRDLIMWLNQLHGEIPQELRDMASLENLILDFNELSGTIPSGLVNCTKLNWISLSNNRLTGEIPSWIGKLSNLAILKLSNNSFSGRIPPELGDCPSLIWLDLNTNFLTGPIPPELAKQSGKVVVNFISGKTYVYIKNDGSKECHGAGSLLEFAGINQEQLGRISTRNPCNFTRVYGGKLQPTFTLNGSMIFLDVSHNMLSGTIPKEIGEMVFLYVLHLSHNNLSGSIPQELGRMKNLNILDLSYNKLQDQIPQTLTRLSLLTEIDFSNNCLSGTIPESGQFDTFPVGKFLNNSGLCGVPLPPCGADLGGGAGSQHKSHRRQASLAGSVAMGLLFSLFCVFGLIIIAIETRKRRKKKEAAIDGYIENSHSGNANNSGWKLTSAREALSINLATFEKPLRKLTFADLLAATNGFHNDSLIGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDPKKAGIKMNWSVRRKIAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSADFGDNNLVGWVKQHAKLKISDVFDKELMKEDPNLEIELLQHLKVACACLDDRPWRRPTMIQVMAMFKEIQAGSGMDSQSTIAAEDEGFNAIEMVEMSIKEVPESNKH | 1182 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vifa2g03111 | 1182 | FunFam | serine/threonine-protein kinase BRI1-like 2 | 830 | 944 | - | - | |
Vifa2g03111 | 1182 | Gene3D | Ribonuclease Inhibitor | 33 | 760 | IPR032675 | - | |
Vifa2g03111 | 1182 | FunFam | Serine/threonine-protein kinase BRI1-like 1 | 584 | 641 | - | - | |
Vifa2g03111 | 1182 | SUPERFAMILY | L domain-like | 44 | 399 | - | - | |
Vifa2g03111 | 1182 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 641 | 759 | - | - | |
Vifa2g03111 | 1182 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 991 | 1003 | IPR008271 | GO:0004672|GO:0006468 | |
Vifa2g03111 | 1182 | FunFam | LRR receptor-like serine/threonine-protein kinase GSO1 | 163 | 404 | - | - | |
Vifa2g03111 | 1182 | ProSiteProfiles | Protein kinase domain profile. | 869 | 1144 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g03111 | 1182 | Gene3D | Transferase(Phosphotransferase) domain 1 | 945 | 1146 | - | - | |
Vifa2g03111 | 1182 | PANTHER | LEUCINE-RICH REPEAT RECEPTOR PROTEIN KINASE EMS1 | 65 | 279 | - | - | |
Vifa2g03111 | 1182 | SUPERFAMILY | L domain-like | 284 | 743 | - | - | |
Vifa2g03111 | 1182 | Pfam | Protein kinase domain | 869 | 1139 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g03111 | 1182 | ProSiteProfiles | Leucine-rich repeat profile. | 120 | 142 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | Pfam | Leucine Rich repeats (2 copies) | 215 | 254 | IPR025875 | - | |
Vifa2g03111 | 1182 | Pfam | Leucine Rich repeat | 307 | 322 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | FunFam | Brassinosteroid LRR receptor kinase | 945 | 1146 | - | - | |
Vifa2g03111 | 1182 | FunFam | LRR receptor-like serine/threonine-protein kinase GSO1 | 405 | 582 | - | - | |
Vifa2g03111 | 1182 | SMART | serkin_6 | 869 | 1141 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vifa2g03111 | 1182 | Pfam | Brassinosteroid receptor island domain | 577 | 641 | IPR045381 | - | |
Vifa2g03111 | 1182 | Pfam | Leucine rich repeat N-terminal domain | 30 | 64 | IPR013210 | - | |
Vifa2g03111 | 1182 | SUPERFAMILY | Protein kinase-like (PK-like) | 855 | 1146 | IPR011009 | - | |
Vifa2g03111 | 1182 | ProSitePatterns | Protein kinases ATP-binding region signature. | 875 | 898 | IPR017441 | GO:0005524 | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 479 | 503 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 356 | 379 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 260 | 287 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 380 | 404 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 527 | 551 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 92 | 115 | IPR003591 | - | |
Vifa2g03111 | 1182 | SMART | LRR_typ_2 | 691 | 715 | IPR003591 | - | |
Vifa2g03111 | 1182 | Gene3D | - | 582 | 642 | - | - | |
Vifa2g03111 | 1182 | Pfam | Leucine Rich Repeat | 262 | 288 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | Gene3D | Phosphorylase Kinase; domain 1 | 830 | 944 | - | - | |
Vifa2g03111 | 1182 | Pfam | Leucine rich repeat | 334 | 393 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | Pfam | Leucine rich repeat | 670 | 726 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | Pfam | Leucine rich repeat | 505 | 562 | IPR001611 | GO:0005515 | |
Vifa2g03111 | 1182 | CDD | STKc_IRAK | 875 | 1144 | - | - | |
Vifa2g03111 | 1182 | PRINTS | Leucine-rich repeat signature | 691 | 704 | - | - | |
Vifa2g03111 | 1182 | PRINTS | Leucine-rich repeat signature | 383 | 396 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vifa2g03111 | Vifa-Chr2 | 890982696 | 890986244 | Dispersed/Transposed |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vifa2g03111 | 32 | 1178 | Receptor kinase-like Gene Family | AT4G39400 | 69.337 | 0.0 | 1515 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_LRR-Xb-1 | Vifa2g03111 | Pkinase | 1.7e-46 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vifa2g03111 | K13415 | - | gmx:100499629 | 1832.77 |